Wave Life Sciences (WVE) said in a regulatory filing that it considers its direct exposure to SVB’s (SIVB) receivership as immaterial, given that the aggregate amount of the company’s cash and restricted cash held at SVB is approximately $1.5M, which is $1.25M in excess of the FDIC-insured amount of $250,000.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on WVE: